TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31912752

Group type: EXPERIMENTAL
Intervention: Integrated rehabilitation programme (3 weeks inpatient stay + 12 weeks home-based activities)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Existing rehabilitation programme (4 weeks inpatient stay)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Integrated rehabilitation programme
Number of subjects: 165

Group type: COMPARATOR
Intervention: Existing rehabilitation programme
Number of subjects: 165
Study: 30763457

Group type: EXPERIMENTAL
Intervention: Whole-Grain (WG) diet
Number of subjects: 13

Group type: COMPARATOR
Intervention: Refined-Grain (RG) diet
Number of subjects: 13
Study: 29351103

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 28929695

Group type: EXPERIMENTAL
Intervention: Astragali Radix group 1 (10 g•d⁻¹)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Astragali Radix group 2 (5 g•d⁻¹)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control group (conventional medical treatment)
Number of subjects: 226
Study: 25126034

Group type: EXPERIMENTAL
Intervention: Home portable monitoring (WatchPAT200)
Number of subjects: 75

Group type: COMPARATOR
Intervention: In-laboratory polysomnography (PSG)
Number of subjects: 75
Study: 22171802

Group type: EXPERIMENTAL
Intervention: Tomato juice containing 90 mmol Na (B)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Tomato juice containing 140 mmol Na (C)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sodium-free tomato juice (A)
Number of subjects: 23
Study: 19294951

Group type: EXPERIMENTAL
Intervention: Extended sleep (10 h time in bed)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Habitual sleep (mean 7.09 h time in bed)
Number of subjects: 24
Study: 17213242

Group type: EXPERIMENTAL
Intervention: Adelaide Driving Self-Efficacy Scale (ADSES)
Number of subjects: 81

Group type: COMPARATOR
Intervention: ADSES scores for stroke patients
Number of subjects: 81

Group type: COMPARATOR
Intervention: ADSES scores for participants who passed or failed the on-road assessment
Number of subjects: 81
Study: 15666257

Group type: EXPERIMENTAL
Intervention: Oxylator EM-100 (manual mode)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oxylator EM-100 (automatic mode)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bag-valve device
Number of subjects: 40
Study: 11300580

Group type: EXPERIMENTAL
Intervention: Integrity-repair exercise after the threat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Threat of deliberative mind-set induced uncertainty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mortality salience and temporal discontinuity threats
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uncertainty-related threats
Number of subjects: 0
Study: 9399755

Group type: EXPERIMENTAL
Intervention: RBC 400 mg b.i.d., amoxicillin 1 g b.i.d., and clarithromycin 500 mg b.i.d. (RAC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: RBC 400 mg b.i.d., metronidazole 250 mg t.i.d., and tetracycline 500 mg t.i.d. (RMT)
Number of subjects: 100
Study: 8198928

Group type: EXPERIMENTAL
Intervention: Diltiazem (60 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Verapamil (80 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 2907080

Group type: EXPERIMENTAL
Intervention: Propranolol (PROP) 80 mg b.i.d.
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Atenolol (ATEN) 100 mg o.d.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 28
Study: 29276031

Group type: EXPERIMENTAL
Intervention: CPR training with a manikin in a hospital bed
Number of subjects: 108

Group type: COMPARATOR
Intervention: CPR training with a manikin on the floor
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Optimised working position (regardless of training method)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Non-optimised working position (regardless of training method)
Number of subjects: 108
Study: 28185775

Group type: COMPARATOR
Intervention: Gravity group (n=50)
Number of subjects: 150

Group type: COMPARATOR
Intervention: 20-lbf group (n=50)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 30-lbf group (n=50)
Number of subjects: 150
Study: 26691535

Group type: EXPERIMENTAL
Intervention: PACT + TAU
Number of subjects: 152

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 152
Study: 23239126

Group type: EXPERIMENTAL
Intervention: Group culture of good and poor quality embryos separately (Method B)
Number of subjects: 874

Group type: COMPARATOR
Intervention: Group culture of embryos randomly regardless of quality (Method A)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 874
Study: 21608219

Group type: EXPERIMENTAL
Intervention: Tongxinluo Capsule (TXL)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 160
Study: 18424988

Group type: COMPARATOR
Intervention: Rigid registration without correction of geometric distortion
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Rigid registration with compensation for geometric distortion
Number of subjects: 11

Group type: COMPARATOR
Intervention: Comparison of alignment accuracy
Number of subjects: 11
Study: 17238499

Group type: EXPERIMENTAL
Intervention: Email reminders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postal reminders
Number of subjects: 0
Study: 12960927

Group type: EXPERIMENTAL
Intervention: Graded reoxygenation (paO2: 50‐70 mmHg, n=10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional hyperoxic reoxygenation (paO2: >250 mmHg, n=9)
Number of subjects: 19
Study: 10653873

Group type: EXPERIMENTAL
Intervention: Early initiation of adjuvant chemotherapy within 20 days after surgery (599 patients, 84 with ER-absent tumors)
Number of subjects: 1788

Group type: COMPARATOR
Intervention: Conventional initiation of adjuvant chemotherapy 21 to 86 days after surgery (1,189 patients, 142 with ER-absent tumors)
Number of subjects: 1788

Group type: EXPERIMENTAL
Intervention: Early initiation of chemotherapy for ER-expressing tumors (1,562 patients)
Number of subjects: 1788
Study: 9209181

Group type: EXPERIMENTAL
Intervention: 1.25-MJ liquid meal
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 2.92-MJ liquid meal
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Refeeding (general)
Number of subjects: 11
Study: 8218004

Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel and 20 micrograms ethinyl oestradiol (Mercilon)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel and 30 micrograms ethinyl oestradiol (Marvelon/Desolett)
Number of subjects: 1000
Study: 3302842

Group type: EXPERIMENTAL
Intervention: Relaxation training (6 weekly sessions of 75 min duration in progressive relaxation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (attention control)
Number of subjects: 40
Study: 31609666

Group type: EXPERIMENTAL
Intervention: STEPS
Number of subjects: 59

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 59
Study: 30646281

Group type: EXPERIMENTAL
Intervention: Standardized program for identification, assessment, and treatment of osteoporosis led by a trained coordinating nurse.
Number of subjects: 82578

Group type: COMPARATOR
Intervention: Control period (2008-2015) without the intervention.
Number of subjects: 82578
Study: 26945918

Group type: EXPERIMENTAL
Intervention: Liver outcome score predicting 5-year liver-related death
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Liver outcome score predicting 5-year liver decompensation
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Liver outcome score predicting 5-year hepatocellular carcinoma (HCC) occurrence
Number of subjects: 617
Study: 23990572

Group type: EXPERIMENTAL
Intervention: Efavirenz (600 mg/d) plus standard antituberculosis treatment (rifampicin and isoniazid)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Efavirenz (600 mg/d) alone
Number of subjects: 307

Group type: COMPARATOR
Intervention: Standard antituberculosis treatment (rifampicin and isoniazid)
Number of subjects: 307
Study: 21986244

Group type: EXPERIMENTAL
Intervention: Tailored brief tobacco cessation interventions by lay health influencers
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Training curriculum for lay health influencers
Number of subjects: 80
Study: 19783599

Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) for 1 year post-transplant
Number of subjects: 388

Group type: COMPARATOR
Intervention: No Isoniazid (Control group)
Number of subjects: 388
Study: 19166443

Group type: EXPERIMENTAL
Intervention: ERN/LRPT 2 g
Number of subjects: 1611

Group type: EXPERIMENTAL
Intervention: ERN 1 g
Number of subjects: 1611

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1611
Study: 16174011

Group type: EXPERIMENTAL
Intervention: Tilt Table Test (TTT) positive
Number of subjects: 81

Group type: COMPARATOR
Intervention: Tilt Table Test (TTT) negative
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: ILR activation
Number of subjects: 81
Study: 12373599

Group type: EXPERIMENTAL
Intervention: Explicit statement mentioning 'a computer', 'chance', and 'not the doctor's or patient's decision'
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Succinct statement that played down the role of 'chance'
Number of subjects: 741

Group type: COMPARATOR
Intervention: Analogy of 'a computer will perform the equivalent of tossing a coin to allocate you to one of two methods of treatment'
Number of subjects: 741
Study: 9697553

Group type: EXPERIMENTAL
Intervention: Peer-led health education course
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 0
Study: 7510728

Group type: EXPERIMENTAL
Intervention: Pentastarch
Number of subjects: 29

Group type: COMPARATOR
Intervention: Albumin
Number of subjects: 29
Study: 2675752

Group type: EXPERIMENTAL
Intervention: Norfloxacin, 200 mg orally daily at bedtime
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 30
Study: 174244

Group type: EXPERIMENTAL
Intervention: DBcAMP administered intravenously at 10 mg/min for 20 min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DBcAMP administered intravenously at 20 mg/min for 20 min
Number of subjects: 10
Study: 7362696

Group type: EXPERIMENTAL
Intervention: Clofibate (2 g/day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oxandrolone (7.5 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: PAS-C (6-8 g/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Colestipol (20 g/day)
Number of subjects: 14
Study: 30407039

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing integrated with Cognitive-Behavioral Therapy (MI-CBT)
Number of subjects: 85
Study: 27807605

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Amitriptyline (during conditioning)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (after evocation)
Number of subjects: 39
Study: 26923487

Group type: EXPERIMENTAL
Intervention: Esophageal speech
Number of subjects: 96

Group type: COMPARATOR
Intervention: Tracheoesophageal fistula and Provox 2 voice prosthesis
Number of subjects: 96

Group type: COMPARATOR
Intervention: Electrolarynx
Number of subjects: 96
Study: 25067799

Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (BAT) for 6 months
Number of subjects: 11
Study: 23069315

Group type: EXPERIMENTAL
Intervention: lamivudine and adefovir diprivoxil combination therapy (LA)
Number of subjects: 150

Group type: COMPARATOR
Intervention: lamivudine alone (L)
Number of subjects: 150

Group type: COMPARATOR
Intervention: adefovir dipivoxil alone (A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: lamivudine and adefovir diprivoxil combination therapy (LA) followed by adefovir monotherapy
Number of subjects: 150
Study: 19545976

Group type: EXPERIMENTAL
Intervention: Olanzapine (7.5 mg)
Number of subjects: 1460

Group type: COMPARATOR
Intervention: Risperidone (1.5 mg), Perphenazine (8 mg), Ziprasidone (40 mg), Quetiapine (200 mg)
Number of subjects: 1460
Study: 17898183

Group type: EXPERIMENTAL
Intervention: NIPH-MeNZB
Number of subjects: 615

Group type: COMPARATOR
Intervention: MenBvac (control)
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: CV-MeNZB
Number of subjects: 615

Group type: COMPARATOR
Intervention: NIPH-MeNZB (control)
Number of subjects: 615
Study: 15138710

Group type: EXPERIMENTAL
Intervention: Imatinib 200 mg alone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Imatinib 200 mg with ketoconazole 400 mg
Number of subjects: 14
Study: 12490790

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 63

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 63
Study: 9698972

Group type: EXPERIMENTAL
Intervention: Placebo drug (sham second drug)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no misattribution)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Tachistoscopic display (placebo)
Number of subjects: 42
Study: 7696728

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 0
Study: 2547464

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate given together and 30 min after diflunisal tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diflunisal (oral administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous administration of diflunisal
Number of subjects: 0
Study: 1103896

Group type: EXPERIMENTAL
Intervention: Verapamil, 240 mg orally
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Verapamil retard, orally
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 7
Study: 31339232

Group type: EXPERIMENTAL
Intervention: Autonomic regulation therapy added to guideline-directed medical therapy (GDMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blocker doses in ANTHEM-HF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blocker doses in ANTHEM-HF vs. PARADIGM-HF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker
Number of subjects: 0
Study: 28496141

Group type: EXPERIMENTAL
Intervention: Prone position ventilation endotracheal tube (PPT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional routine endotracheal tube (TT)
Number of subjects: 80
Study: 26063180

Group type: EXPERIMENTAL
Intervention: snus trial
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: dissolvable tobacco trial
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: medicinal nicotine trial
Number of subjects: 258

Group type: COMPARATOR
Intervention: control group (no trial)
Number of subjects: 258
Study: 24035673

Group type: EXPERIMENTAL
Intervention: Guided internet-delivered cognitive behaviour therapy (ICBT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Group-based cognitive behaviour therapy (CBT)
Number of subjects: 69
Study: 22187792

Group type: EXPERIMENTAL
Intervention: Clonidine 0.5 ml (75 microg) plus 5 ml 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 5 ml 0.25% bupivacaine plus 0.5 ml of normal saline (NS)
Number of subjects: 60
Study: 19001516

Group type: EXPERIMENTAL
Intervention: Intralipid (20%, 40 ml/h) plus heparin (250 units/h)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal saline (40 ml/h) plus heparin (250 units/h)
Number of subjects: 24
Study: 16775568

Group type: EXPERIMENTAL
Intervention: Percutaneous tracheostomy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Surgical tracheostomy
Number of subjects: 200
Study: 15381869

Group type: EXPERIMENTAL
Intervention: Technegas ventilation scintigraphy (TcGS) with thyroid visualization
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Technegas ventilation scintigraphy (TcGS) in a prospective group
Number of subjects: 114
Study: 11450717

Group type: EXPERIMENTAL
Intervention: Heidelberg retina flowmeter (HRF) examination in patients with ischaemic macular branch retinal vein occlusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Heidelberg retina flowmeter (HRF) examination in control group (healthy volunteers)
Number of subjects: 10
Study: 9869250

Group type: EXPERIMENTAL
Intervention: Information pack containing various Stroke Association publications
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (received nothing)
Number of subjects: 71
Study: 8027497

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate eye drops (Opticrom 2%) used regularly (four times daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sodium cromoglycate eye drops (Opticrom 2%) used as needed (up to four times daily)
Number of subjects: 62
Study: 2510274

Group type: EXPERIMENTAL
Intervention: Rioprostil
Number of subjects: 1918

Group type: COMPARATOR
Intervention: Ranitidine (Control)
Number of subjects: 1918

Group type: EXPERIMENTAL
Intervention: Laboratory variables (Rioprostil)
Number of subjects: 1918
Study: 952693

Group type: EXPERIMENTAL
Intervention: 1.5% etiodocaine HCl 20 ml with adrenaline 5 mug/ml
Number of subjects: 5

Group type: COMPARATOR
Intervention: 0.75% bupivacaine HCl 20 ml with adrenaline 5 mug/ml
Number of subjects: 5
Study: 31919049

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 190

Group type: COMPARATOR
Intervention: No adenotonsillectomy (NoAT)
Number of subjects: 190
Study: 30421869

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance training (2 sessions/week for 12 weeks)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (15 matched MeS patients who did not exercise)
Number of subjects: 15
Study: 29041954

Group type: EXPERIMENTAL
Intervention: Compensatory Cognitive Training (CCT) and Supported Employment (SE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 25853602

Group type: EXPERIMENTAL
Intervention: Online cross‐cultural communication module (n=60)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard curriculum only (Control group, n=59)
Number of subjects: 119
Study: 23567927

Group type: EXPERIMENTAL
Intervention: Medifast 5 & 1 Plan (MD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Reduced-energy, food-based diet (FB)
Number of subjects: 120
Study: 22094092

Group type: EXPERIMENTAL
Intervention: Spontaneous respiration
Number of subjects: 76

Group type: COMPARATOR
Intervention: Mechanical ventilation
Number of subjects: 76
Study: 19827465

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg/kg body mass
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 17378844

Group type: EXPERIMENTAL
Intervention: PKVP
Number of subjects: 40

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 40
Study: 15479310

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 47
Study: 12815781

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 102

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 102
Study: 9266456

Group type: EXPERIMENTAL
Intervention: 20 mg BSH/kg body weight administered 2.5‐16 hrs prior to tumor removal
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: BNCT using thermal neutrons
Number of subjects: 11
Study: 8300831

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (0.1 mM)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (higher concentrations)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (2 mM)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 31
Study: 3546611

Group type: EXPERIMENTAL
Intervention: DES-CEF (cyclophosphamide, 600 mg/m2; DES, 1 mg orally on days 5, 6, and 7; epidoxorubicin, 60 mg/m2; 5-fluorouracil, 600 mg/m2)
Number of subjects: 117

Group type: COMPARATOR
Intervention: CEF (cyclophosphamide, 600 mg/m2; epidoxorubicin, 60 mg/m2; 5-fluorouracil, 600 mg/m2)
Number of subjects: 117
Study: 31222615

Group type: EXPERIMENTAL
Intervention: Brief coping-focused psychotherapy (Brief-PsT)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Short-term psychotherapy (Short-PsT)
Number of subjects: 284
Study: 28681986

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study: 30284429

Group type: COMPARATOR
Intervention: Medication (conservative therapy)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Tunneling liver shunt operation
Number of subjects: 55
Study: 25381789

Group type: EXPERIMENTAL
Intervention: Self-management program using goal setting based on G-AP
Number of subjects: 60

Group type: COMPARATOR
Intervention: Patient information leaflets about stroke
Number of subjects: 60
Study: 22795205

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (20 individual sessions)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Psychoeducation (6 sessions)
Number of subjects: 204
Study: 20509923

Group type: EXPERIMENTAL
Intervention: Interventions to optimize job resources and recovery opportunities implemented in 4 intervention wards.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Comparison wards (control group) with no specified interventions.
Number of subjects: 8
Study: 17574801

Group type: EXPERIMENTAL
Intervention: Highly structured contingency management intervention (experimental group, n = 51)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard methadone treatment (control group, n = 49)
Number of subjects: 100
Study: 15850918

Group type: EXPERIMENTAL
Intervention: 125I (144 Gy)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: 103Pd (125 Gy)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: High-dose regions (V100 >= 90%)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: High-dose regions (V100 < 90%)
Number of subjects: 270
Study: 12825092

Group type: EXPERIMENTAL
Intervention: 150 mg oral dose of caffeine freebase
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 10575901

Group type: EXPERIMENTAL
Intervention: Pap-test screening
Number of subjects: 294
Study: 8762218

Group type: EXPERIMENTAL
Intervention: enalapril 20 mg-hydrochlorothiazide 12.5 mg
Number of subjects: 240

Group type: COMPARATOR
Intervention: enalapril 20 mg-nifedipine SL 20 mg x 2
Number of subjects: 240
Study: 1342582

Group type: EXPERIMENTAL
Intervention: 0.5% timolol maleate with 2% pilocarpine hydrochloride given twice a day
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 0.5% timolol with 4% pilocarpine given twice a day
Number of subjects: 360